|
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned therefore no evaluation was completed.At the completion of the clinical assessment, the left limb stent-graft cephalic migration, 1b endoleak, secondary endovascular procedure event were confirmed from the medical records.Procedure-related harms, device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.As the initial procedure is outside the intended of use due to adjunctive devices not compatible per the ifu, this is most likely cause the migration of the stent resulting in a type 1b endoleak.The final patient status was reported to be stable.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Corrections: h6: result code: remove code 3233.H6: conclusion code: remove code 11.
|